Related Experiment Video

Updated: Jun 18, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction

Byung Min Chung1, Srikumar M Raja, Robert J Clubb

  • 1Eppley Institute for Cancer and Allied Diseases, University of Nebraska Medical Center, 985950 Nebraska Medical Center, Omaha, NE 68198-5950, USA. chungj@unmc.edu

BMC Cell Biology
|December 2, 2009
PubMed
Abstract

Insights

Mutant epidermal growth factor receptors (EGFR) in non-small cell lung cancer (NSCLC) traffic abnormally through recycling compartments, promoting interactions with Src and contributing to cancer development.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Signaling

Background:

  • Epidermal growth factor receptor (EGFR) signaling is crucial for cellular functions, and its dysregulation drives cancer, particularly non-small cell lung cancer (NSCLC).
  • Mutant EGFRs in NSCLC are constitutively active, promoting cell transformation via downstream pathways.
  • Endocytic trafficking, especially lysosomal degradation, normally terminates EGFR signaling, but its role in mutant EGFRs in NSCLC is not fully understood.

Purpose of the Study:

  • To investigate the endocytic trafficking patterns of mutant EGFRs in NSCLC.
  • To determine if mutant EGFRs exhibit distinct endocytic routes compared to wild-type EGFR.
  • To explore the functional consequences of mutant EGFR endocytic trafficking on oncogenic signaling.

Main Methods:

  • Utilized NSCLC cell lines expressing mutant EGFRs.
  • Employed immunofluorescence microscopy to assess EGFR colocalization with endosomal markers (transferrin, LAMP1, Rab11, EHD1).
  • Treated cells with the endocytic recycling inhibitor monensin to perturb trafficking pathways.

Main Results:

  • Mutant EGFRs were constitutively endocytosed and colocalized with both early/recycling and late endosomal/lysosomal markers.
  • Monensin treatment caused perinuclear accumulation of mutant EGFRs with recycling markers (Rab11, EHD1), unlike wild-type EGFR.
  • Monensin treatment enhanced the association and colocalization of mutant EGFR with Src, indicating a link between aberrant recycling and Src activation.

Conclusions:

  • Mutant EGFRs in NSCLC exhibit aberrant trafficking into the endocytic recycling compartment.
  • This aberrant trafficking facilitates preferential interaction between mutant EGFR and Src.
  • The mutant EGFR-Src interaction is a critical step in EGFR-mediated oncogenesis in NSCLC.

More Related Videos

Density Gradient Ultracentrifugation for Investigating Endocytic Recycling in Mammalian Cells05:13

Density Gradient Ultracentrifugation for Investigating Endocytic Recycling in Mammalian Cells

Published on: June 30, 2021

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Recycling Endosomes and Transcytosis00:58

Recycling Endosomes and Transcytosis

The recycling endosome, also known as the endosomal recycling compartment (ERC), is a part of the slow-recycling process of the endocytic pathway. Molecules internalized through receptor-mediated endocytosis are either degraded in the lysosomes or are recycled to the plasma membrane through the fast- or slow-recycling route.
The recycling endosome is not a single organelle but an extensively tubulated network of recycling pathways. It functions in storing molecules or transporting them across...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...